MedPath

SUBLIMED

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Identification of Predictive Factors for observAnce of Transcutaneous Electrical NeuroStimulation (TENS) in Chronic Pain

Conditions
Chronic Pain
First Posted Date
2020-02-05
Last Posted Date
2020-02-05
Lead Sponsor
Sublimed
Target Recruit Count
500
Registration Number
NCT04253639

Comparison of the Efficacy, Tolerability and Safety of actiTENS to Those of Level 2 Analgesic Treatments.

Not Applicable
Conditions
Knee Osteoarthritis
Interventions
Device: ActiTENS
Drug: Level 2 Analgesic Treatments
First Posted Date
2019-04-04
Last Posted Date
2019-04-04
Lead Sponsor
Sublimed
Target Recruit Count
110
Registration Number
NCT03902340
Locations
🇫🇷

Hôpital Roger Salengro, Lille, France

News

No news found
© Copyright 2025. All Rights Reserved by MedPath